BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 16299657)

  • 1. [Expression of glutathione S-transferase-pi and DNA topoisomerase II alpha and their implications in colorectal carcinoma].
    Ou XL; Sun WH; Xu M; Cao DZ; Yu Q; Yu T; Sun YL; Jiang J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2005 Nov; 8(6):524-7. PubMed ID: 16299657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
    Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
    Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression of P-gp, GST-pi and Topo II alpha in gastric and colorectal cancers and their clinical significance].
    Chen WY; Mao WM; Zhao L; Chen GP; Shu Y; Shen YF; Zhu XH; Xia Y
    Zhonghua Zhong Liu Za Zhi; 2005 Dec; 27(12):738-40. PubMed ID: 16483485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of multidrug resistance-related proteins p-glycoprotein, glutathione-s-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
    Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
    Hepatogastroenterology; 2008; 55(86-87):1530-6. PubMed ID: 19102336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relationship of cyclooxygenase-2 and multidrug resistance associated factors to chemosensitivities in gastrointestinal carcinomas].
    Tan BB; Li Y; Han J; Fan LQ; Zhao Q; Song ZC; Wang D
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Jan; 41(1):128-31. PubMed ID: 20369487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidrug resistance-associated biomarkers PGP, GST-pi, Topo-II and LRP as prognostic factors in primary ovarian carcinoma.
    Lu D; Shi HC; Wang ZX; Gu XW; Zeng YJ
    Br J Biomed Sci; 2011; 68(2):69-74. PubMed ID: 21706917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression and significance of P-glycoprotein, glutathione S-transferase-pi and Topoisomerase II in gastric carcinomas].
    Qin F; Qin X; Zhang X; Jia HW
    Ai Zheng; 2002 Feb; 21(2):167-70. PubMed ID: 12479068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression and significance of MRP, GST-pi, Topo IIalpha, and LRP in gastric carcinoma].
    Yu DQ; Yi YF
    Ai Zheng; 2003 May; 22(5):496-9. PubMed ID: 12753710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The expression of MRP, GST-pi, Topo IIalpha and COX-2 in epithelial ovarian cancer and its relationship to drug resistance and prognosis].
    Cao DY; Shen K; Yang JX; Guan J
    Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(25):1738-41. PubMed ID: 17919376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression and implication of Pgp, MRP, LRP, GST-pi, Topo II alpha in tongue squamous cell carcinoma].
    Leng WD; Wang DZ; Feng G; He J
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2004 Feb; 22(1):23-5. PubMed ID: 15017692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of topoisomerase II alpha in human colorectal carcinoma and its significance].
    Yang FD; Jia ZL
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Aug; 30(8):1959-61, 1964. PubMed ID: 20813715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy of hepatic arterial infusion of adriamycin and mitomycin C mixed with degradable starch microspheres for liver metastasis of colorectal cancer--correlation with the mRNA expression of DNA topoisomerase-IIalpha and glutathione-S transferase-pi in primary lesions].
    Ishida H; Shirakawa K; Takeuchi I; Nakada H; Ohsawa T; Hayashi Y; Okada N; Yokoyama M; Inokuma S; Hashimoto D; Osada H; Matsumoto Y; Miura T
    Gan To Kagaku Ryoho; 2004 Oct; 31(11):1803-5. PubMed ID: 15553721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of the drug resistance markers DNA topoisomerase II alpha and glutathione S-transferase-pi in the histological compartments of Wilms' tumors.
    Granzen B; Efferth T; Keller U; Beniers AJ; Mertens R; Jakse G; Füzesi L
    Anticancer Res; 2001; 21(1B):771-6. PubMed ID: 11299842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of multidrug resistance gene-related proteins in the postoperative chemotherapy of gastric cancer.
    Yu P; Du Y; Yang L; Fan S; Wu J; Zheng S
    Int J Clin Exp Pathol; 2014; 7(11):7945-50. PubMed ID: 25550836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between chemosensitivity and Pgp, GST-π and Topo II expression in gastric cancer.
    Geng M; Wang L; Chen X; Cao R; Li P
    Diagn Pathol; 2013 Dec; 8():198. PubMed ID: 24326092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of resistance factors (P-glycoprotein, glutathione S-transferase-pi, and topoisomerase II) and their interrelationship to proto-oncogene products in renal cell carcinomas.
    Volm M; Kästel M; Mattern J; Efferth T
    Cancer; 1993 Jun; 71(12):3981-7. PubMed ID: 8099529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significance of multidrug resistance gene-associated proteins in the postoperative adjuvant chemotherapy for gastric carcinoma and the prognosis].
    Yu PF; Guo JM; Xu Q; Ying JE; Wang XJ; Cheng XD; Wang XB; Yu CD
    Zhonghua Wei Chang Wai Ke Za Zhi; 2010 Apr; 13(4):289-93. PubMed ID: 20422488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlation of the expression of MDR genes and MDR genes-coded product with prognosis in laryngopharyngeal malignant melanoma].
    Chen X; Ji T; Yao L; Yang J; Deng J; Zhang Z
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2002 Sep; 16(9):459-61. PubMed ID: 15515530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topoisomerase II alpha expression in esophageal squamous cell carcinoma.
    Ohashi Y; Sasano H; Yamaki H; Shizawa S; Kikuchi A; Shineha R; Akaishi T; Satomi S; Nagura H
    Anticancer Res; 1999; 19(3A):1873-80. PubMed ID: 10470130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical expression of topoisomerase II alpha and Her-2/neu in prostatic carcinoma and benign prostatic hyperplasia.
    Hasby EA; Saied EM
    J Egypt Natl Canc Inst; 2008 Jun; 20(2):158-67. PubMed ID: 20029472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.